The import of vaccines for human use in Brazil is projected to grow steadily from 2024 to 2028. Based on the available forecast data, the import value in 2024 is expected to be USD 757.53 million, reaching USD 807.46 million by 2028. This represents a consistent year-on-year increase.

Since the data from 2023 is not provided, a comparison against previous actual values is not possible. However, the projected Compound Annual Growth Rate (CAGR) over this five-year period indicates a stable growth trajectory in vaccine imports, implying strong demand and possibly increased government initiatives towards vaccination efforts.

Future trends to watch for include:

Possible variations due to changes in global vaccine supply chains.
Impact of domestic vaccine production capacity expansion in Brazil.
Potential influence of new healthcare policies and government budget allocations on import levels.
Emerging market dynamics influenced by new vaccine types and global health emergencies.